Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers
Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers
Not yet recruiting · NCT07529951 · Registry updated 2026-04-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, primary myelofibrosis | Not yet recruiting | Phase 1 | 2026-04-14 | NCT07529951 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eilean Therapeutics | 4 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||